Neurosciences
Protein modifications key influencers in neurodegenerative diseases
Research
EPFL
Exploring the post-translational modifications of a key protein in Parkinson's disease, researchers at EPFL and USC uncover potential pathways for future therapies in neurodegenerative diseases in general.
Visualising multiple sclerosis with a new MRI procedure
Research
ETH Zurich
The loss of myelin sheaths in the brain is a hallmark of multiple sclerosis. Researchers at ETH Zurich have now developed an MRI method that maps the condition of this nerve insulation layer more accurately than before.
New agent blocks stress response
Research
ETH Zurich
If the body’s natural stress response gets knocked off balance, it can result in physical and mental health disorders. Researchers at ETH Zurich have developed an agent capable of selectively inhibiting this response.
Clarifying the cause of Guillain-Barré Syndrome
Research
ETH Zurich
Guillain-Barré Syndrome is a rare condition in which a person’s immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH Zurich has now clarified the mechanism of this autoimmune disease.
Methods for bypassing and treating spinal cord injury
TechTransfer
EPFL
Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here’s a look at some of the promising new therapies they’ve developed.
More parallel 'traffic' observed in human brains than in animals
Research
EPFL
In a study comparing human brain communication networks with those of macaques and mice, EPFL researchers found that only the human brains transmitted information via multiple parallel pathways, yielding new insights into mammalian evolution.
Page 1 of 13